Also trades as: CCO.TO (TSX) · $vol 85M · 0R35.L (LSE) · $vol 2M

$82.42

+3.35 (+4.23%)

After Hours: $82.65 (+0.23, +0.29%)

Weekly Expected Move ±5.9%

$69 $74 $79 $83 $88

NYSE · Energy · Uranium · Tech Score Strong Sell · Power 35 · $34.4B mcap · 434M float · 0.738% daily turnover · Short 41% of daily vol

Credit Risk of going bust: lower than 74% of companies Debt: 2.0% of company value Bonds: none of note held by US funds details ▾

If the stock fell to about $0.19 (down 99.8%), Cameco Corporation would be worth roughly what it owes.
Total debt $720.4M against a stock market value of $34.44B.
Distance to default 8.34 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $355.9M (short-term plus half of long-term), stock volatility 54.3%; Altman Z'' 4.97. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets

$95

Low

$117

Avg Target

$138

High

Based on 5 analysts since Jul 31, 2026 earnings

Analyst Recommendations

Strong Buy: 1Buy: 13Hold: 5Sell: 2Strong Sell: 0

Rating Summary

ConsensusBuy

Avg Target$117.00

Analysts5

Price Target Change History

Date	Firm	Analyst	Old	New	Change	Upside @ Call	Stock@Call
2026-10-22	Truist Financial	Christopher Souther	$130	$125	-5	+52.4%	$82.02
2026-10-19	Barclays	—	$97	$95	-2	+16.5%	$81.52
2026-09-03	Jefferies	—	Initiated	$138	—	+43.2%	$96.38
2026-08-12	Truist Financial	—	$129	$130	+1	+30.9%	$99.31
2026-08-04	Barclays	—	$104	$97	-7	+8.1%	$89.72
2026-07-15	Barclays	—	$108	$104	-4	+13.6%	$91.57
2026-07-13	Truist Financial	—	Initiated	$129	—	+43.0%	$90.20
2026-06-15	Bernstein	Bob Brackett	$147	$135	-12	+26.2%	$106.96
2026-05-21	Barclays	—	Initiated	$108	—	+2.5%	$105.33
2026-05-06	Scotiabank	Orest Wowkodaw	$38	$175	+137	+52.9%	$114.46
2026-02-05	Bernstein	Bob Brackett	$101	$147	+46	+33.7%	$109.97
2026-02-04	Goldman Sachs	—	$109	$131	+22	+3.8%	$126.15
2026-01-07	Bernstein	—	$70	$101	+31	-1.1%	$102.09
2025-12-03	GLJ Research	—	$38	$100	+62	+14.8%	$86.85
2025-10-29	Goldman Sachs	—	$55	$109	+54	+2.9%	$105.95
2025-09-09	UBS	—	Initiated	$102	—	+31.8%	$77.39
2025-09-09	CLSA	Max Hopkins	Initiated	$102	—	+32.2%	$77.14
2025-06-10	Bernstein	Bob Brackett	Initiated	$70	—	+9.7%	$63.83
2024-04-01	Goldman Sachs	Neil Mehta	Initiated	$55	—	+27.0%	$43.32
2021-10-31	Scotiabank	Orest Wowkodaw	Initiated	$38	—	+51.6%	$25.07
2021-08-31	GLJ Research	Gordon Johnson	Initiated	$38	—	+98.8%	$19.11

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B-

Oct 27, 2026

DCF

ROE

ROA

D/E

P/E

P/B

The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CCJ receives an overall rating of B-. Areas of concern: P/E (1/5), P/B (1/5).

Rating Change History

Date	From	To
2026-08-03	B	B-
2026-07-01	B+	B
2026-05-18	B	B+
2026-05-06	B-	B
2026-05-04	B	B-
2026-04-28	B-	B
2026-04-01	B	B-
2026-03-02	B-	B
2026-02-17	B	B-
2026-01-26	B-	B

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade B

Profitability

Balance Sheet

Earnings Quality

Growth

Value

—

Momentum

Safety

—

Cash Flow

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score

—

Piotroski F-Score

5/9

✓ ✓ ✗ ✓ ✓ ✓ ✗ ✗ ✗

Beneish M-Score

-2.50

Unlikely Manipulator

Ohlson O-Score

-9.57

Bankruptcy prob: 0.0%

Low Risk

Credit Rating

A+

Score: 75.0/100

Trend: Deteriorating

Earnings Quality

75/100

OCF/NI: 2.59x

Accruals: -5.7%

The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CCJ scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CCJ's score of -2.50 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CCJ's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CCJ receives an estimated rating of A+ (score: 75.0/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). CCJ's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E

141.73x

PEG

-4.25x

P/S

14.53x

P/B

7.07x

P/FCF

—

P/OCF

—

EV/EBITDA

—

EV/Revenue

—

EV/EBIT

—

EV/FCF

—

Earnings Yield

—

FCF Yield

—

Shareholder Yield

—

Graham Number

$17.34

Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 141.7x earnings, CCJ is priced for high growth expectations. Graham's intrinsic value formula yields $17.34 per share, 356% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden

0.754

NI / EBT

Interest Burden

0.844

EBT / EBIT

EBIT Margin

0.161

EBIT / Rev

Asset Turnover

0.349

Rev / Assets

Equity Multiplier

1.433

Assets / Equity

ROE

5.1%

The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CCJ's ROE of 5.1% is driven by Asset Turnover (0.349), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate

15.00%

Fair P/E

38.50x

Intrinsic Value

$31.39

Price/Value

—

Margin of Safety

—

Premium

—

Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with CCJ's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. CCJ actually compounded EPS at 53.6% over three years; the model uses 15%, the highest rate it will extrapolate — of 4,457 company-quarters that grew faster than 200%, none sustained it over the following seven years. CCJ trades at a premium to its adjusted intrinsic value of $31.39, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 38.5x compares to the current market P/E of 141.7x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price

$79.08

Median 1Y

$96.06

5th Pctile

$40.94

95th Pctile

$225.25

Ann. Volatility

49.6%

Analyst Target

$117.00

25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees

—

Revenue / Employee

—

Rev: $3,479,095,453

Profit / Employee

—

NI: $589,096,533

SGA / Employee

—

Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
ROE	-0.7%	-2.1%	-1.2%	1.4%	2.4%	1.7%	3.1%	2.0%	4.8%	6.0%	3.9%	4.2%	1.9%	2.8%	3.9%	8.2%	8.1%	8.9%	11.2%	5.1%	5.12%
ROA	-0.5%	-1.4%	-0.8%	1.0%	1.6%	1.1%	2.1%	1.4%	3.3%	3.9%	2.6%	2.8%	1.3%	1.7%	2.6%	5.6%	5.5%	5.8%	7.8%	3.6%	3.57%
ROIC	-1.3%	-2.4%	-1.7%	0.5%	1.0%	0.2%	1.4%	0.6%	3.2%	2.9%	2.8%	3.6%	2.4%	4.8%	5.6%	6.9%	7.1%	6.9%	9.3%	5.4%	5.42%
ROCE	0.6%	-0.6%	0.1%	2.0%	2.0%	0.5%	0.9%	0.6%	2.6%	4.7%	4.5%	4.7%	4.2%	4.4%	5.4%	8.9%	8.2%	9.2%	13.2%	5.9%	5.87%
Gross Margin	-7.2%	12.0%	12.5%	27.6%	18.7%	17.8%	35.5%	22.8%	36.1%	15.7%	29.5%	29.3%	23.7%	21.1%	34.2%	29.3%	37.3%	22.2%	35.7%	21.1%	21.06%
Operating Margin	-18.0%	-0.5%	1.7%	15.1%	-4.4%	-11.2%	13.8%	7.3%	23.6%	2.1%	20.0%	17.0%	13.9%	15.3%	23.5%	18.9%	15.1%	13.6%	19.4%	10.4%	10.41%
Net Margin	-20.0%	2.4%	10.1%	15.1%	-5.0%	-2.9%	17.3%	2.8%	25.7%	9.5%	-1.1%	6.0%	1.0%	11.4%	8.8%	36.6%	-0.0%	16.6%	15.5%	3.1%	3.10%
EBITDA Margin	-2.4%	18.4%	23.7%	26.1%	7.7%	-6.0%	24.9%	20.3%	33.3%	22.2%	15.8%	25.8%	20.4%	22.3%	26.5%	57.1%	14.8%	29.4%	29.9%	20.6%	20.58%
FCF Margin	30.9%	24.4%	29.4%	22.5%	7.7%	8.6%	9.6%	9.1%	18.5%	20.7%	14.6%	16.7%	10.5%	19.2%	19.2%	25.2%	28.1%	30.9%	26.1%	15.4%	15.38%
OCF Margin	36.3%	31.1%	37.0%	30.1%	15.8%	16.3%	16.1%	16.0%	24.9%	26.6%	21.2%	22.8%	16.9%	25.5%	25.7%	32.4%	36.4%	40.5%	36.1%	26.5%	26.49%
ROE 3Y Avg	snapshot only																				5.68%
ROE 5Y Avg	snapshot only																				4.07%
ROA 3Y Avg	snapshot only																				3.92%
ROIC 3Y Avg	snapshot only																				4.88%
ROIC Economic	snapshot only																				4.72%
Cash ROA	snapshot only																				8.94%
Cash ROIC	snapshot only																				13.09%
CROIC	snapshot only																				7.60%
NOPAT Margin	snapshot only																				10.96%
Pretax Margin	snapshot only																				13.55%
R&D / Revenue	snapshot only																				1.40%
SGA / Revenue	snapshot only																				10.46%
SBC / Revenue	snapshot only																				0.83%

Valuation

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
P/E Ratio	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	141.732
P/S Ratio	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	14.525
P/B Ratio	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	7.075
P/FCF	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
P/OCF	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EV/EBITDA	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EV/Revenue	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EV/EBIT	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EV/FCF	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Earnings Yield	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Yield	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Graham Number	snapshot only																				$17.34

Leverage & Solvency

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Current Ratio	6.34	5.18	5.05	6.02	5.11	5.92	7.75	3.64	3.85	1.55	1.42	3.22	2.88	1.62	2.71	2.96	2.99	2.47	3.08	3.06	3.061
Quick Ratio	4.71	3.96	3.91	4.84	3.76	4.46	6.36	2.86	3.17	0.84	0.54	1.20	0.96	0.80	0.99	1.75	1.57	1.68	2.09	2.10	2.100
Debt/Equity	0.21	0.21	0.21	0.20	0.22	0.17	0.19	0.19	0.18	0.29	0.28	0.25	0.20	0.20	0.15	0.15	0.15	0.15	0.14	0.14	0.141
Net Debt/Equity	-0.07	-0.07	-0.09	-0.09	-0.06	-0.22	-0.23	-0.23	-0.25	0.20	0.23	0.20	0.18	0.11	0.10	0.04	0.03	-0.03	-0.02	-0.01	-0.015
Debt/Assets	0.14	0.13	0.14	0.14	0.14	0.12	0.13	0.13	0.13	0.18	0.18	0.17	0.14	0.13	0.11	0.11	0.10	0.10	0.10	0.10	0.098
Debt/EBITDA	3.93	6.76	5.62	2.47	2.97	4.19	3.56	4.22	2.63	2.76	2.96	2.48	2.15	1.95	1.29	0.90	0.95	0.89	0.60	1.17	1.169
Net Debt/EBITDA	-1.32	-2.28	-2.36	-1.03	-0.82	-5.40	-4.30	-5.04	-3.59	1.88	2.40	1.91	1.87	1.05	0.82	0.26	0.21	-0.17	-0.07	-0.12	-0.120
Interest Coverage	0.54	-0.78	0.07	1.94	2.49	0.69	1.23	0.84	3.52	5.37	4.17	3.78	3.02	3.47	4.69	9.35	9.54	11.41	11.50	7.09	7.093
Equity Multiplier	1.52	1.55	1.53	1.50	1.53	1.48	1.44	1.45	1.43	1.63	1.55	1.51	1.50	1.56	1.45	1.42	1.44	1.49	1.43	1.44	1.443
Cash Ratio	snapshot only																				1.394
Debt Service Coverage	snapshot only																				10.987
Cash to Debt	snapshot only																				1.103
FCF to Debt	snapshot only																				0.529
Defensive Interval	snapshot only																				1154.9 days

Efficiency & Turnover

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Asset Turnover	0.21	0.20	0.21	0.27	0.24	0.23	0.27	0.29	0.28	0.28	0.28	0.29	0.31	0.32	0.35	0.38	0.36	0.34	0.42	0.35	0.349
Inventory Turnover	2.25	2.31	2.62	3.29	2.64	2.26	2.90	2.84	2.60	2.28	2.49	2.24	2.57	2.59	2.60	3.07	2.58	2.71	3.37	3.34	3.336
Receivables Turnover	7.06	6.75	8.01	10.02	9.56	8.52	13.20	10.03	8.52	8.90	14.25	11.82	9.27	8.67	18.49	15.39	13.96	10.75	25.36	11.06	11.058
Payables Turnover	5.93	8.40	5.71	7.63	5.38	6.47	5.65	6.79	5.97	6.12	6.36	7.52	6.77	9.44	6.71	7.62	6.38	15.34	7.49	5.33	5.333
DSO	52	54	46	36	38	43	28	36	43	41	26	31	39	42	20	24	26	34	14	33	33.0 days
DIO	162	158	139	111	138	162	126	129	140	160	146	163	142	141	141	119	142	135	108	109	109.4 days
DPO	62	43	64	48	68	56	65	54	61	60	57	49	54	39	54	48	57	24	49	68	68.4 days
Cash Conversion Cycle	152	169	121	100	109	148	89	111	122	142	115	145	128	144	106	95	111	145	74	74	74.0 days
Fixed Asset Turnover	snapshot only																				1.014
Operating Cycle	snapshot only																				142.4 days
Cash Velocity	snapshot only																				3.121
Capital Intensity	snapshot only																				2.965

Growth (YoY)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue	-26.5%	-18.1%	-9.3%	12.9%	15.9%	26.6%	36.3%	16.8%	25.4%	38.5%	17.5%	27.4%	23.3%	21.2%	29.9%	34.7%	23.9%	11.0%	7.4%	-2.7%	-2.70%
Net Income	-6.3%	-92.9%	-47.4%	3.8%	4.4%	1.9%	3.9%	54.0%	1.3%	3.0%	39.8%	1.6%	-56.1%	-52.4%	5.9%	1.1%	3.5%	2.4%	1.6%	-33.4%	-33.45%
EPS	-6.3%	-92.0%	-46.4%	3.8%	4.4%	1.8%	3.7%	41.8%	1.1%	3.0%	39.9%	1.6%	-56.1%	-52.6%	5.6%	1.1%	3.5%	2.4%	1.6%	-33.5%	-33.46%
FCF	7.8%	4.4%	3.0%	75.3%	-71.2%	-55.2%	-55.4%	-52.9%	2.0%	2.3%	78.3%	1.3%	-30.2%	12.4%	71.0%	1.0%	2.3%	79.0%	45.9%	-40.7%	-40.70%
EBITDA	-20.6%	-35.1%	-17.8%	29.7%	37.2%	61.6%	69.7%	-15.7%	20.7%	1.7%	83.2%	1.4%	37.3%	2.8%	34.4%	77.0%	80.9%	73.3%	54.5%	-22.9%	-22.94%
Op. Income	-3.2%	-73.0%	12.6%	1.3%	1.9%	1.1%	2.0%	1.3%	1.9%	17.8%	2.1%	6.0%	67.4%	80.3%	80.8%	65.9%	80.7%	19.3%	3.1%	-20.2%	-20.16%
OCF Growth	snapshot only																				-20.48%
Asset Growth	snapshot only																				7.50%
Equity Growth	snapshot only																				5.87%
Debt Growth	snapshot only																				0.20%
Shares Change	snapshot only																				0.01%
Dividend Growth	snapshot only																				50.01%

Growth (CAGR)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue 3Y	-9.0%	-11.0%	-6.7%	-3.9%	-0.2%	0.1%	4.1%	0.5%	2.2%	12.9%	13.3%	18.9%	21.5%	28.6%	27.6%	26.1%	24.2%	23.1%	17.9%	18.6%	18.62%
Revenue 5Y	-9.1%	-9.5%	-8.1%	-5.9%	-4.1%	-2.8%	-0.4%	0.1%	1.8%	4.3%	5.4%	5.8%	9.0%	11.0%	11.5%	11.8%	10.3%	14.1%	15.2%	17.1%	17.09%
EPS 3Y	—	—	—	-24.7%	3.0%	3.5%	27.9%	27.8%	—	—	—	—	—	—	—	97.7%	60.7%	87.1%	56.9%	53.6%	53.63%
EPS 5Y	—	—	—	—	—	—	—	—	—	14.6%	18.1%	9.7%	0.1%	16.1%	25.3%	62.6%	—	—	—	—	—
Net Income 3Y	—	—	—	-24.4%	3.2%	6.5%	32.0%	31.8%	—	—	—	—	—	—	—	1.0%	65.5%	87.5%	57.0%	53.7%	53.74%
Net Income 5Y	—	—	—	—	—	—	—	—	—	16.8%	20.3%	11.8%	2.0%	18.4%	27.8%	65.7%	—	—	—	—	—
EBITDA 3Y	9.3%	-29.3%	-21.3%	-10.2%	-8.2%	-21.6%	-14.5%	-15.1%	9.6%	41.8%	36.7%	37.4%	31.5%	65.3%	61.0%	52.4%	44.2%	69.2%	56.1%	47.9%	47.89%
EBITDA 5Y	-6.7%	-9.7%	-0.9%	-3.7%	26.8%	3.3%	4.6%	16.1%	16.7%	9.2%	8.7%	7.7%	5.1%	6.1%	9.0%	20.7%	26.7%	38.4%	39.6%	28.7%	28.74%
Gross Profit 3Y	-44.8%	-81.3%	-27.9%	-3.6%	7.9%	15.3%	29.5%	36.6%	53.2%	86.8%	1.7%	1.3%	1.3%	6.4%	1.1%	59.5%	44.6%	40.4%	23.2%	23.1%	23.10%
Gross Profit 5Y	-37.8%	-66.6%	-25.6%	-12.3%	-1.3%	-3.2%	4.6%	6.3%	15.0%	18.6%	21.1%	21.9%	20.3%	26.5%	27.2%	36.0%	40.8%	57.2%	1.0%	76.1%	76.07%
Op. Income 3Y	—	—	—	-25.0%	-2.0%	-45.4%	-5.4%	-4.6%	82.8%	—	—	—	—	—	—	2.0%	1.1%	2.4%	78.7%	1.1%	1.11%
Op. Income 5Y	—	—	—	6.9%	—	—	—	—	—	32.1%	71.2%	46.4%	35.5%	40.7%	36.2%	59.0%	79.2%	—	—	—	—
FCF 3Y	-17.5%	-16.3%	3.2%	10.2%	-17.2%	-24.7%	-23.9%	-5.0%	—	—	—	24.7%	-15.3%	18.7%	10.7%	31.0%	91.2%	88.3%	64.5%	41.5%	41.49%
FCF 5Y	8.2%	30.4%	3.4%	-7.9%	-18.7%	-19.7%	-23.1%	-23.4%	-13.3%	-2.7%	-2.7%	8.2%	3.6%	9.8%	6.1%	32.5%	—	—	—	18.5%	18.51%
OCF 3Y	-15.2%	-11.8%	7.4%	14.5%	-2.7%	-12.0%	-14.1%	4.5%	—	—	—	26.6%	-5.9%	20.4%	13.1%	29.3%	64.0%	66.6%	54.3%	40.3%	40.35%
OCF 5Y	0.2%	8.0%	0.1%	-6.8%	-11.6%	-12.6%	-16.9%	-16.2%	-9.5%	0.6%	2.6%	11.1%	8.7%	12.3%	9.1%	31.7%	—	—	—	25.3%	25.35%
Assets 3Y	-2.1%	-2.1%	-2.0%	-10.7%	-0.2%	14.7%	18.1%	4.7%	4.8%	9.4%	8.6%	8.0%	7.8%	9.6%	7.8%	18.6%	9.3%	6.0%	-5.5%	5.9%	5.94%
Assets 5Y	-2.7%	-1.8%	-1.6%	-6.3%	-0.6%	2.1%	2.1%	2.3%	2.0%	4.4%	3.6%	3.1%	4.3%	11.6%	12.4%	4.9%	5.2%	6.3%	-0.4%	6.7%	6.72%
Equity 3Y	0.2%	-1.0%	-0.5%	-8.1%	-0.1%	14.9%	20.0%	6.7%	7.8%	7.1%	7.1%	7.8%	8.5%	9.5%	9.9%	20.7%	11.5%	5.7%	-5.2%	6.1%	6.11%
Book Value 3Y	0.0%	-1.2%	-0.8%	-8.3%	-0.3%	11.6%	16.3%	3.4%	4.5%	3.9%	4.0%	4.6%	5.3%	6.2%	6.8%	17.3%	8.3%	5.5%	-5.3%	6.0%	6.03%
Dividend 3Y	0.5%	8.5%	8.3%	8.3%	8.4%	14.4%	14.1%	14.1%	14.0%	-2.9%	-2.8%	-2.9%	-2.9%	6.8%	7.1%	7.1%	7.0%	14.2%	14.4%	14.4%	14.39%

Growth Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue Stability	0.73	0.98	0.97	0.79	0.48	0.48	0.12	0.05	0.00	0.09	0.32	0.34	0.59	0.60	0.66	0.61	0.65	0.88	0.94	0.92	0.916
Earnings Stability	0.03	0.00	0.16	0.15	0.52	0.04	0.20	0.27	0.50	0.10	0.21	0.20	0.26	0.38	0.59	0.76	0.71	0.77	0.85	0.79	0.791
Margin Stability	0.43	0.29	0.40	0.53	0.50	0.26	0.26	0.42	0.35	0.20	0.23	0.42	0.46	0.36	0.52	0.60	0.61	0.56	0.48	0.53	0.531
Rev. Growth Consistency	0.00	0.00	0.00	0.50	0.50	0.50	0.50	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	0.00	0.000
Earn. Growth Consistency	0.00	0.00	0.00	0.50	0.50	0.50	0.50	1.00	1.00	1.00	1.00	1.00	0.00	0.00	1.00	1.00	0.50	0.50	1.00	0.00	0.000
FCF Positive Streak	0	0	0	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
Earnings Persistence	0.50	0.50	0.50	0.20	0.20	0.20	0.20	0.50	0.50	0.50	0.50	0.50	0.50	0.50	0.98	0.50	0.50	0.50	0.50	0.87	0.866
Earnings Smoothness	—	—	—	—	—	—	—	0.57	0.22	0.00	0.67	0.10	0.22	0.29	0.94	0.30	0.00	0.00	0.11	0.60	0.598
ROE Trend	-0.02	-0.03	-0.02	0.01	0.03	0.03	0.04	0.01	0.04	0.06	0.03	0.03	-0.01	-0.01	0.00	0.05	0.05	0.04	0.09	-0.01	-0.011
Gross Margin Trend	-0.08	-0.09	-0.02	0.06	0.12	0.17	0.22	0.17	0.18	0.17	0.09	0.07	0.00	0.02	0.01	0.01	0.03	0.04	0.04	0.01	0.014
FCF Margin Trend	0.26	0.17	0.24	0.10	-0.06	-0.01	0.02	-0.09	-0.01	0.04	-0.05	0.01	-0.03	0.05	0.07	0.12	0.14	0.11	0.09	-0.06	-0.056
Sustainable Growth Rate	—	—	—	0.7%	1.7%	0.7%	2.1%	0.9%	3.9%	5.2%	3.0%	3.4%	1.0%	1.6%	2.8%	7.2%	7.0%	7.3%	9.4%	3.6%	3.61%
Internal Growth Rate	—	—	—	0.5%	1.1%	0.5%	1.5%	0.6%	2.7%	3.4%	2.1%	2.3%	0.7%	1.0%	1.9%	5.1%	5.0%	5.0%	7.0%	2.6%	2.59%

Cash Flow Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
OCF/Net Income	-16.66	-4.47	-10.22	8.44	2.47	3.41	2.07	3.41	2.13	1.91	2.28	2.35	4.05	4.65	3.41	2.17	2.40	2.39	1.96	2.59	2.592
FCF/OCF	0.85	0.78	0.79	0.75	0.49	0.53	0.60	0.57	0.74	0.78	0.69	0.73	0.62	0.75	0.75	0.78	0.77	0.76	0.72	0.58	0.581
FCF/Net Income	snapshot only																				1.505
OCF/EBITDA	snapshot only																				1.066
CapEx/Revenue	5.3%	6.7%	7.6%	7.6%	8.1%	7.7%	6.5%	6.9%	6.4%	5.9%	6.6%	6.1%	6.4%	6.3%	6.5%	7.2%	8.3%	9.6%	10.0%	11.1%	11.11%
CapEx/Depreciation	snapshot only																				1.261
Accruals Ratio	-0.08	-0.07	-0.09	-0.07	-0.02	-0.03	-0.02	-0.03	-0.04	-0.04	-0.03	-0.04	-0.04	-0.06	-0.06	-0.07	-0.08	-0.08	-0.08	-0.06	-0.057
Sloan Accruals	snapshot only																				0.015
Cash Flow Adequacy	snapshot only																				1.877
Earnings Quality Score	snapshot only																				0.750

Dividends & Buybacks

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Dividend Yield	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0.21%
Dividend/Share	$0.06	$0.08	$0.08	$0.08	$0.08	$0.12	$0.12	$0.12	$0.12	$0.12	$0.12	$0.12	$0.12	$0.16	$0.16	$0.16	$0.16	$0.24	$0.24	$0.24	$0.24
Payout Ratio	—	—	—	50.2%	27.4%	58.1%	30.9%	53.1%	19.6%	14.4%	22.2%	20.3%	44.7%	40.5%	28.0%	13.1%	13.2%	17.7%	16.1%	29.4%	29.42%
FCF Payout Ratio	5.1%	8.9%	6.8%	7.9%	22.9%	32.2%	25.0%	27.5%	12.4%	9.7%	14.1%	11.8%	17.8%	11.6%	11.0%	7.7%	7.2%	9.7%	11.3%	19.5%	19.55%
Total Payout Ratio	—	—	—	50.2%	27.4%	58.1%	30.9%	53.1%	19.6%	14.4%	22.2%	20.3%	44.7%	40.5%	28.0%	13.1%	13.2%	17.7%	16.1%	29.4%	29.42%
Div. Increase Streak	0	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
Chowder Number	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Buyback Yield	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Buyback Yield	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total Shareholder Return	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

DuPont Factors

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Tax Burden (NI/EBT)	2.03	0.99	0.99	0.67	0.67	0.62	0.65	0.52	0.72	0.74	0.66	0.69	0.51	0.67	0.70	0.77	0.79	0.76	0.80	0.75	0.754
Interest Burden (EBT/EBIT)	-0.38	2.41	-15.33	0.88	1.24	3.70	3.69	3.83	1.83	1.19	0.94	0.89	0.63	0.67	0.75	0.87	0.89	0.91	0.92	0.84	0.844
EBIT Margin	0.03	-0.03	0.00	0.06	0.08	0.02	0.03	0.02	0.09	0.16	0.15	0.16	0.13	0.12	0.14	0.22	0.21	0.24	0.25	0.16	0.161
Asset Turnover	0.21	0.20	0.21	0.27	0.24	0.23	0.27	0.29	0.28	0.28	0.28	0.29	0.31	0.32	0.35	0.38	0.36	0.34	0.42	0.35	0.349
Equity Multiplier	1.54	1.54	1.51	1.50	1.53	1.51	1.48	1.47	1.47	1.56	1.50	1.48	1.46	1.59	1.50	1.47	1.46	1.52	1.44	1.43	1.433

Per Share

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
EPS (Diluted TTM)	$-0.09	$-0.26	$-0.14	$0.16	$0.29	$0.21	$0.39	$0.22	$0.61	$0.83	$0.54	$0.59	$0.27	$0.39	$0.57	$1.23	$1.21	$1.35	$1.49	$0.82	$0.82
Book Value/Share	$12.22	$12.18	$12.22	$9.59	$12.27	$13.49	$13.71	$13.75	$14.04	$14.04	$14.08	$14.21	$14.26	$14.58	$14.91	$15.48	$15.57	$15.84	$11.66	$16.39	$16.38
Tangible Book/Share	$12.09	$12.05	$12.10	$9.49	$12.15	$13.38	$13.60	$13.64	$13.94	$13.94	$13.98	$14.11	$14.17	$14.49	$14.82	$15.39	$15.49	$15.76	$11.60	$16.31	$16.31
Revenue/Share	$3.92	$3.71	$3.96	$4.45	$4.54	$4.32	$4.96	$4.79	$5.21	$5.96	$5.84	$6.08	$6.42	$7.19	$7.56	$8.20	$7.96	$7.99	$8.12	$7.98	$7.98
FCF/Share	$1.21	$0.90	$1.16	$1.00	$0.35	$0.37	$0.48	$0.43	$0.97	$1.23	$0.85	$1.02	$0.67	$1.38	$1.45	$2.07	$2.23	$2.47	$2.12	$1.23	$1.16
OCF/Share	$1.42	$1.15	$1.46	$1.34	$0.72	$0.70	$0.80	$0.77	$1.30	$1.58	$1.23	$1.39	$1.08	$1.83	$1.94	$2.66	$2.90	$3.23	$2.93	$2.11	$2.04
Cash/Share	$3.42	$3.35	$3.70	$2.77	$3.37	$5.28	$5.69	$5.69	$6.13	$1.31	$0.74	$0.83	$0.37	$1.38	$0.83	$1.64	$1.79	$2.79	$1.83	$2.56	$2.55
EBITDA/Share	$0.65	$0.37	$0.46	$0.79	$0.89	$0.55	$0.72	$0.61	$0.99	$1.49	$1.33	$1.45	$1.35	$1.53	$1.78	$2.57	$2.45	$2.65	$2.75	$1.98	$1.98
Debt/Share	$2.56	$2.50	$2.61	$1.95	$2.65	$2.31	$2.58	$2.59	$2.59	$4.11	$3.94	$3.61	$2.90	$2.97	$2.29	$2.31	$2.31	$2.35	$1.64	$2.32	$2.32
Net Debt/Share	$-0.86	$-0.84	$-1.09	$-0.82	$-0.73	$-2.97	$-3.12	$-3.10	$-3.54	$2.80	$3.19	$2.78	$2.53	$1.59	$1.46	$0.67	$0.52	$-0.44	$-0.19	$-0.24	$-0.24

Academic Models

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Altman Z-Score	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Piotroski F-Score	3	3	3	7	6	8	8	5	7	5	6	6	4	7	8	8	9	9	8	5	5
Beneish M-Score	-3.51	-1.56	-4.50	-3.37	-2.86	-2.95	-2.71	-1.68	-2.58	-1.28	-1.53	-2.38	-1.63	-2.99	-2.86	-2.02	-3.54	-2.75	-3.41	-2.50	-2.504
Ohlson O-Score	snapshot only																				-9.565
ROIC (Greenblatt)	snapshot only																				10.99%
Net-Net WC	snapshot only																				$-1.65
EVA	snapshot only																				$-322442725.13

Credit

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Credit Rating	snapshot only																				A+
Credit Score	51.01	40.84	46.76	55.50	55.97	46.04	52.15	46.85	65.74	59.12	53.26	58.72	59.06	60.44	70.18	77.37	77.89	81.87	81.68	75.05	75.047
Credit Grade	snapshot only																				5
Credit Trend	snapshot only																				-2.322
Implied Spread (bps)	snapshot only																				125.000
Industry Credit Rank	snapshot only																				70
Sector Credit Rank	snapshot only																				75

CCJ NYSE

Analyst Insights

Financial Rating

InsiderStreet Scorecard

Risk & Quality Signals

Valuation

DuPont Decomposition (5-Factor)

Graham-Dodd Adjusted Valuation

Profitability Trends

Leverage & Solvency Trends

Efficiency & Working Capital Trends

Growth Trends (YoY %)

Earnings Stability

Monte Carlo Price Simulation

Workforce & Productivity

Scaling Efficiency

Sign in to InsiderStreet